Aristides Capital LLC Purchases Shares of 60,000 Genpact Limited (NYSE:G)

Aristides Capital LLC bought a new stake in Genpact Limited (NYSE:G - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 60,000 shares of the business services provider's stock, valued at approximately $1,931,000. Genpact comprises 0.5% of Aristides Capital LLC's portfolio, making the stock its 28th biggest position.

A number of other hedge funds and other institutional investors have also bought and sold shares of G. CWM LLC grew its holdings in Genpact by 160.8% during the second quarter. CWM LLC now owns 952 shares of the business services provider's stock worth $31,000 after purchasing an additional 587 shares during the period. Massmutual Trust Co. FSB ADV grew its holdings in Genpact by 120.0% during the first quarter. Massmutual Trust Co. FSB ADV now owns 1,813 shares of the business services provider's stock worth $60,000 after purchasing an additional 989 shares during the period. Parallel Advisors LLC grew its holdings in Genpact by 22.6% during the fourth quarter. Parallel Advisors LLC now owns 1,882 shares of the business services provider's stock worth $65,000 after purchasing an additional 347 shares during the period. Versant Capital Management Inc boosted its holdings in shares of Genpact by 4,717.8% during the second quarter. Versant Capital Management Inc now owns 2,168 shares of the business services provider's stock worth $70,000 after acquiring an additional 2,123 shares during the period. Finally, Quarry LP boosted its holdings in shares of Genpact by 530.1% during the fourth quarter. Quarry LP now owns 2,073 shares of the business services provider's stock worth $72,000 after acquiring an additional 1,744 shares during the period. Institutional investors own 96.03% of the company's stock.

Genpact Price Performance

Shares of NYSE:G traded up $0.22 during trading on Tuesday, hitting $39.43. 1,105,367 shares of the company were exchanged, compared to its average volume of 1,375,042. The business's 50 day moving average is $37.36 and its 200-day moving average is $34.11. The company has a market capitalization of $7.10 billion, a P/E ratio of 11.26, a price-to-earnings-growth ratio of 1.63 and a beta of 1.13. The company has a quick ratio of 1.89, a current ratio of 1.89 and a debt-to-equity ratio of 0.52. Genpact Limited has a 1-year low of $29.41 and a 1-year high of $39.95.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The business services provider reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.64 by $0.05. The company had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.15 billion. Genpact had a net margin of 14.12% and a return on equity of 22.28%. Equities analysts forecast that Genpact Limited will post 2.85 earnings per share for the current year.

Genpact Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Wednesday, September 11th were paid a $0.1525 dividend. The ex-dividend date of this dividend was Wednesday, September 11th. This represents a $0.61 annualized dividend and a dividend yield of 1.55%. Genpact's dividend payout ratio is 17.43%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on G shares. TD Cowen boosted their price objective on Genpact from $35.00 to $36.00 and gave the stock a "hold" rating in a report on Friday, August 9th. BMO Capital Markets boosted their price objective on Genpact from $38.00 to $42.00 and gave the stock a "market perform" rating in a report on Monday, August 12th. Jefferies Financial Group boosted their price objective on Genpact from $35.00 to $40.00 and gave the stock a "hold" rating in a report on Monday, September 9th. Needham & Company LLC lifted their price target on shares of Genpact from $40.00 to $42.00 and gave the company a "buy" rating in a research report on Friday, August 9th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Genpact from $35.00 to $43.00 and gave the company a "neutral" rating in a research report on Friday, September 6th. Eight equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $38.78.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.